Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Clin Cancer Res. 2020 Jan 22;26(11):2595–2602. doi: 10.1158/1078-0432.CCR-19-1669

Figure 1. Correlation of clinical outcomes and genomic alterations in African American cohort.

Figure 1.

(A) Kaplan-Meier plot of metastasis-free survival by quartile of percent genome alteration. (B) Oncoprint showing distribution of somatic mutations and copy number alterations for AA cohort. (C) Kaplan-Meier plot of metastasis-free survival by presence of TP53 mutation compared to wild type. (D) Kaplan-Meier plot of metastasis-free survival by presence of CDKN1B deep deletions compared to wild type.